Consumer Assessment of Tobacco Flavor and Odor
- Conditions
- Current VaperHealthy Subject
- Interventions
- Behavioral: Behavioral InterventionOther: Questionnaire Administration
- Registration Number
- NCT04358315
- Lead Sponsor
- Roswell Park Cancer Institute
- Brief Summary
This trial studies consumer assessments of tobacco flavor and odor. This study will compare the ability of expert and consumer panels to identify and characterize flavors, determine threshold detection levels for individual and mixed flavors, and identify the dominant flavor of mixtures.
- Detailed Description
PRIMARY OBJECTIVE:
I. Develop consumer (untrained) sensory panels to identify and assess characterizing flavors in electronic (e)-liquids.
OUTLINE:
Non-user panelists smell and user panelists puff flavored e-liquids and answer questions about the products.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 29
- CONSUMER USER: Current daily vapers of products containing nicotine
- CONSUMER USER: No concurrent use of other tobacco products
- CONSUMER USER: General good health
- CONSUMER USER: No allergies
- CONSUMER USER: No self-reported taste or smell deficits
- CONSUMER USER: Not pregnant or lactating
- CONSUMER USER: No medications known to interfere with taste/smell
- CONSUMER USER: Passing scores on the Brief Smell Identification Test (B-SIT), phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests
- CONSUMER USER: No positive diagnosis of COVID-19 within 30 days
- CONSUMER NONUSER: No use of tobacco or nicotine products in the last year
- CONSUMER NONUSER: General good health
- CONSUMER NONUSER: No allergies
- CONSUMER NONUSER: No self-reported taste or smell deficits
- CONSUMER NONUSER: Not pregnant or lactating
- CONSUMER NONUSER: No medications known to interfere with taste/smell
- CONSUMER NONUSER: Passing scores on the Brief Smell Identification Test (B-SIT), phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests
- CONSUMER NONUSER: No positive diagnosis of COVID-19 within 30 days
- CONSUMER USER: Outside age range
- CONSUMER USER: Not current daily vapers
- CONSUMER USER: Concurrent use of other tobacco products
- CONSUMER USER: Fair or poor general health
- CONSUMER USER: Allergies
- CONSUMER USER: Self-reported taste or smell deficits
- CONSUMER USER: Pregnant or lactating
- CONSUMER USER: Medications known to interfere with taste/smell
- CONSUMER USER: Failing scores on the Brief Smell Identification Test (B-SIT), phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests
- CONSUMER USER: Positive diagnosis of COVID-19 within 30 days
- CONSUMER NONUSER: Outside age range
- CONSUMER NONUSER: Use of tobacco or nicotine products in the last year
- CONSUMER NONUSER: Fair or poor general health
- CONSUMER NONUSER: Allergies
- CONSUMER NONUSER: Self-reported taste or smell deficits
- CONSUMER NONUSER: Pregnant or lactating
- CONSUMER NONUSER: Medications known to interfere with taste/smell
- CONSUMER NONUSER: Failing scores on the Brief Smell Identification Test (B-SIT), phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests
- CONSUMER NONUSER: Positive diagnosis of COVID-19 within 30 days
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Observational (smell or puff e-liquids) Behavioral Intervention All panel participants smell and user panelists puff flavored e-liquids and answer questions about the products. Observational (smell or puff e-liquids) Questionnaire Administration All panel participants smell and user panelists puff flavored e-liquids and answer questions about the products.
- Primary Outcome Measures
Name Time Method Flavor combination thresholds Up to 12 months Subjects will rate a combination of two e-liquids combined
Flavor identification and evaluation Up to 12 months Subjects will be asked to identify various concentrations of flavored e-liquids
Specific flavor detection thresholds Up to 12 months Subjects will rate intensity of odors of e liquids
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Roswell Park Cancer Institute
🇺🇸Buffalo, New York, United States